AstraZeneca PLC (NASDAQ:AZN) Announces Dividend of 1.60

AstraZeneca PLC (NASDAQ:AZN) declared a dividend on Tuesday, February 10th. Investors of record on Friday, February 20th will be given a dividend of 1.595 per share on Monday, March 23rd. The ex-dividend date of this dividend is Friday, February 20th.

AstraZeneca has raised its dividend payment by an average of 0.0%per year over the last three years. AstraZeneca has a payout ratio of 39.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect AstraZeneca to earn $5.00 per share next year, which means the company should continue to be able to cover its $2.02 annual dividend with an expected future payout ratio of 40.4%.

AstraZeneca Stock Up 3.0%

Shares of NASDAQ:AZN traded up $5.60 during midday trading on Tuesday, reaching $193.61. The company had a trading volume of 1,585,837 shares, compared to its average volume of 4,269,538. AstraZeneca has a 1-year low of $122.48 and a 1-year high of $195.90. The stock has a market cap of $300.27 billion, a PE ratio of 64.31, a P/E/G ratio of 1.59 and a beta of 0.34. The company has a quick ratio of 0.69, a current ratio of 0.88 and a debt-to-equity ratio of 0.54. The business’s 50 day moving average price is $103.79 and its 200 day moving average price is $89.45.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company headquartered in Cambridge, England. Formed through the 1999 merger of Sweden’s Astra AB and the UK’s Zeneca Group, the company researches, develops, manufactures and commercializes prescription medicines across a range of therapeutic areas. AstraZeneca’s operations span research and development, large-scale manufacturing, and commercial distribution, with a presence in developed and emerging markets worldwide.

The company focuses on several core therapy areas including oncology, cardiovascular, renal and metabolism (CVRM), respiratory and immunology, and rare diseases.